J45.40

Moderate persistent asthma, uncomplicated

Moderate persistent asthma (J45.40) is a clinical classification of asthma severity defined by symptoms that occur daily. In this stage of the disease, the patient experiences symptoms every day and uses a short-acting beta-agonist (SABA) for symptom relief daily. Nighttime awakenings due to asthma symptoms occur more than once a week but not every night. Normal activity is somewhat limited, and objective lung function testing typically reveals a forced expiratory volume in 1 second (FEV1) between 60% and 80% of the predicted value, with an FEV1/FVC ratio reduced by approximately 5%. The designation 'uncomplicated' indicates that at the time of the clinical encounter, the patient is not experiencing an acute exacerbation or status asthmaticus. Clinical management for moderate persistent asthma usually requires a step-up in therapy, such as medium-dose inhaled corticosteroids (ICS) or a combination of low-dose ICS and long-acting beta-agonists (LABA).

Clinical Symptoms

Daily coughing episodes
Daily wheezing upon exertion or at rest
Shortness of breath (dyspnea) occurring daily
Chest tightness and pressure
Nighttime awakenings due to asthma symptoms (3-6 times per month)
Daily reliance on rescue inhalers (short-acting beta-agonists)
Reduced exercise tolerance
Fatigue resulting from sleep interruption
FEV1 between 60% and 80% of predicted values
Peak expiratory flow (PEF) variability greater than 30%

Common Causes

Genetic predisposition to airway hyperresponsiveness
Atopy and allergic sensitization
Chronic exposure to indoor allergens such as dust mites and pet dander
Environmental tobacco smoke exposure
Ambient air pollution and particulate matter
Occupational exposure to chemical irritants or industrial dust
Recurrent viral respiratory infections (e.g., rhinovirus, RSV)
Obesity-related systemic inflammation
Comorbid gastroesophageal reflux disease (GERD)

Documentation & Coding Tips

Distinguish symptom frequency to validate moderate persistence.

Example: Patient reports daily symptoms of wheezing and chest tightness. Nighttime awakenings occur 4 times per month (once weekly). SABA used daily for symptom control. Documentation supports J45.40 based on daily frequency, impacting the HCC 112 risk adjustment score by confirming chronic moderate severity without acute exacerbation.

Billing Focus: Document daily symptom occurrence and weekly nighttime awakenings to justify J45.40 over J45.30.

Incorporate objective pulmonary function testing data.

Example: Office spirometry performed today shows an FEV1 of 72 percent predicted with an FEV1/FVC ratio reduced by 5 percent. This objective data aligns with the moderate persistent classification (FEV1 60 to 80 percent). Clinical note specifies J45.40 as the patient is currently stable on current ICS-LABA regimen.

Billing Focus: Include FEV1 percentages (60-80%) to support the medical necessity of moderate persistent asthma coding.

Explicitly state the absence of acute exacerbation or status asthmaticus.

Example: Moderate persistent asthma, uncomplicated. Patient is here for routine follow-up. No cough, increased sputum, or increased SOB noted over baseline. No recent ER visits or oral corticosteroid bursts. Current status is stable and uncomplicated, justifying J45.40 rather than J45.41.

Billing Focus: The term uncomplicated excludes J45.41 (exacerbation) or J45.42 (status asthmaticus).

Document interference with normal activity levels.

Example: Patient notes some limitation in vigorous physical activities like jogging but can perform activities of daily living without significant impairment. This some limitation level is consistent with moderate persistent asthma guidelines. Plan includes continuing Advair 250/50.

Billing Focus: Activity limitation level helps define the persistent category (Mild vs. Moderate vs. Severe).

Capture all active comorbid respiratory conditions.

Example: Patient has moderate persistent asthma (J45.40) and comorbid allergic rhinitis (J30.9). Asthma is currently uncomplicated. Environmental triggers include pollen and dust mites. Both conditions are managed to optimize asthma control.

Billing Focus: Listing comorbidities supports higher complexity levels for E/M coding (e.g., 99214).

Relevant CPT Codes

99213 - Office or other outpatient visit, established patient, 20-29 minutes
Appropriate for a routine follow-up of stable moderate persistent asthma where two or more stable chronic illnesses or one stable chronic illness are addressed.
99214 - Office or other outpatient visit, established patient, 30-39 minutes
Used when the asthma is poorly controlled or when multiple comorbidities (like GERD or Sinusitis) are being managed simultaneously.
94010 - Spirometry, including graphic record, total capacity and expiratory flow rate measurement
Essential for confirming the severity of asthma and monitoring response to therapy in moderate persistent cases.
94060 - Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration
Used to confirm the diagnosis of asthma by showing significant improvement in FEV1 after bronchodilator use.
94664 - Demonstration and evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device
Ensuring correct inhaler technique is critical for patients with moderate persistent asthma on maintenance therapy.
94760 - Noninvasive ear or pulse oximetry for oxygen saturation; single determination
Used as a quick assessment of respiratory status during an office visit for asthma monitoring.
95004 - Percutaneous tests (scratch, puncture, prick) with allergenic extracts
Identifying and mitigating triggers is a key component of managing moderate persistent asthma.
99203 - Office or other outpatient visit, new patient, 30-44 minutes
Appropriate for an initial consultation of a patient with a straightforward history of persistent asthma.
99204 - Office or other outpatient visit, new patient, 45-59 minutes
Used for new patients with moderate asthma and other chronic conditions requiring comprehensive review.
94640 - Pressurized or nonpressurized inhalation treatment for acute airway obstruction
While J45.40 is uncomplicated, this service might be provided if a patient develops symptoms during a visit.